Epo d + 5-fu/gemcitabine

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7068 (2006.01) A61K 31/427 (2006.01) A61K 31/429 (2006.01) A61K 31/513 (2006.01) A61K 31/7088 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2499682

Methods and compositions for treating hyperproliferative diseases using combinations of one or more epothilones and one or more nucleoside analogs. In some embodiments, the combination includes epothilone D and 5-fluorouracil or 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine.

L'invention concerne des procédés et des compositions pour le traitement de maladies hyperprolifératives au moyen de combinaisons d'une ou plusieurs épothilones et d'un ou plusieurs analogues de nucléoside. Sous certaines variantes, on décrit une combinaison d'épothilone D et de 5-fluoro-uracile ou de 5'-désoxy-5-fluoro-N-[(pentyloxy)carbonyle]-cytidine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Epo d + 5-fu/gemcitabine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Epo d + 5-fu/gemcitabine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epo d + 5-fu/gemcitabine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1916461

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.